The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Immuneering Corp shares valued at $52,730 were purchased by Feinberg Peter on Sep 30 ’25. At $7.03 per share, Feinberg Peter acquired 7,500 shares. The insider’s holdings grew to 149,266 shares worth approximately $0.95 million following the completion of this transaction.
Also, Feinberg Peter purchased 5,000 shares, netting a total of over 35,900 in proceeds. Following the buying of shares at $7.18 each, the insider now holds 141,766 shares.
Before that, BERMAN ANN E had added 14,000 shares to its account. In a trade valued at $136,080, the Director bought Immuneering Corp shares for $9.72 each.
As published in a research note from Morgan Stanley on December 13, 2024, Immuneering Corp [IMRX] has been rated down from an Equal-weight to an Underweight. Analysts at Needham resumed the stock at ‘”a Buy”‘ outlook in a report released in mid March. As of March 15, 2024, TD Cowen has decreased its “an Outperform” rating to a “Market perform” for IMRX. Earlier on March 15, 2024, Jefferies downgraded its rating. Their new recommendation was “a Hold” for IMRX stock which previously was a “a Buy”.
Analyzing IMRX Stock Performance
On last trading session, Immuneering Corp [NASDAQ: IMRX] plunged -9.14% to $6.36. The stock’s lowest price that day was $6.3, but it reached a high of $7.05 in the same session. During the last five days, there has been a drop of approximately -31.09%. Over the course of the year, Immuneering Corp shares have jumped approximately 139.10%. Shares of the company reached a 52-week high of $10.08 on 09/22/25 and a 52-week low of $1.10 on 05/12/25.
Support And Resistance Levels for Immuneering Corp (IMRX)
According to the 24-hour chart, there is a support level at 6.09, which, if violated, would cause prices to drop to 5.82. In the upper region, resistance lies at 6.84. The next price resistance is at 7.32. RSI (Relative Strength Index) is 44.93 on the 14-day chart, showing neutral technical sentiment.
Is Immuneering Corp subject to short interest?
Stocks of Immuneering Corp saw a sharp rise in short interest on 2025-09-15 jumping by 1.38 million shares to 2.96 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 1.58 million shares. A jump of 46.54% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.4 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.4.
Which companies own the most shares of Immuneering Corp (IMRX)?
In terms of Immuneering Corp share price expectations, FactSet research, analysts set an average price target of 30 in the next 12 months, up nearly 328.57% from the previous closing price of $7.0. Analysts anticipate Immuneering Corp stock to reach 30 by 2025, with the lowest price target being 30. In spite of this, 3 analysts ranked Immuneering Corp stock as Buy at the end of 2025. On December 01, 2023, Needham assigned a price target of “a Buy” to the stock and initiated coverage with a $20.
